BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 37071471)

  • 81. Current Aspects of Clonal Hematopoiesis: Implications for Clinical Diagnosis.
    Karner K; George TI; Patel JL
    Ann Lab Med; 2019 Nov; 39(6):509-514. PubMed ID: 31240877
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Clonal hematopoiesis: Mutation-specific adaptation to environmental change.
    Florez MA; Tran BT; Wathan TK; DeGregori J; Pietras EM; King KY
    Cell Stem Cell; 2022 Jun; 29(6):882-904. PubMed ID: 35659875
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions.
    Shin TH; Zhou Y; Chen S; Cordes S; Grice MZ; Fan X; Lee BC; Aljanahi AA; Hong SG; Vaughan KL; Mattison JA; Kohama SG; Fabre MA; Uchida N; Demirci S; Corat MAF; Métais JY; Calvo KR; Buscarlet M; Natanson H; McGraw KL; List AF; Busque L; Tisdale JF; Vassiliou GS; Yu KR; Dunbar CE
    Blood; 2022 Oct; 140(16):1774-1789. PubMed ID: 35714307
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis.
    Zioni N; Bercovich AA; Chapal-Ilani N; Bacharach T; Rappoport N; Solomon A; Avraham R; Kopitman E; Porat Z; Sacma M; Hartmut G; Scheller M; Muller-Tidow C; Lipka D; Shlush E; Minden M; Kaushansky N; Shlush LI
    Nat Commun; 2023 Apr; 14(1):2070. PubMed ID: 37045808
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets.
    Vlasschaert C; Mack T; Heimlich JB; Niroula A; Uddin MM; Weinstock J; Sharber B; Silver AJ; Xu Y; Savona M; Gibson C; Lanktree MB; Rauh MJ; Ebert BL; Natarajan P; Jaiswal S; Bick AG
    Blood; 2023 May; 141(18):2214-2223. PubMed ID: 36652671
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women.
    Wiedmeier JE; Kato C; Zhang Z; Lee H; Dunlap J; Nutt E; Rattray R; McKay S; Eide C; Press R; Mori M; Druker B; Dao KH
    Exp Hematol; 2016 Sep; 44(9):857-865.e5. PubMed ID: 27235757
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling.
    Hormaechea-Agulla D; Matatall KA; Le DT; Kain B; Long X; Kus P; Jaksik R; Challen GA; Kimmel M; King KY
    Cell Stem Cell; 2021 Aug; 28(8):1428-1442.e6. PubMed ID: 33743191
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Clonal Hematopoiesis and the Heart: a Toxic Relationship.
    Jensen JL; Easaw S; Anderson T; Varma Y; Zhang J; Jensen BC; Coombs CC
    Curr Oncol Rep; 2023 May; 25(5):455-463. PubMed ID: 36920637
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cost-Effective and Scalable Clonal Hematopoiesis Assay Provides Insight into Clonal Dynamics.
    Mack T; Vlasschaert C; von Beck K; Silver AJ; Heimlich JB; Poisner H; Condon HR; Ulloa J; Sochacki AL; Spaulding TP; Kishtagari A; Bejan CA; Xu Y; Savona MR; Jones A; Bick AG
    J Mol Diagn; 2024 Jul; 26(7):563-573. PubMed ID: 38588769
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood.
    Schuermans A; Nakao T; Ruan Y; Koyama S; Yu Z; Uddin MM; Haidermota S; Hornsby W; Lewandowski AJ; Bick AG; Niroula A; Jaiswal S; Ebert BL; Natarajan P; Honigberg MC
    J Am Heart Assoc; 2023 Jul; 12(13):e030220. PubMed ID: 37345823
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer.
    Barbui T; Gavazzi A; Sciatti E; Finazzi MC; Ghirardi A; Carioli G; Carobbio A
    Curr Hematol Malig Rep; 2023 Aug; 18(4):105-112. PubMed ID: 37221411
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
    Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
    JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk.
    Kishtagari A; Khan MAW; Li Y; Vlasschaert C; Marneni N; Silver AJ; von Beck K; Spaulding T; Stockton S; Snider C; Sochacki A; Dorand D; Mack TM; Ferrell PB; Xu Y; Bejan CA; Savona MR; Bick AG
    Blood Cancer J; 2024 Jan; 14(1):6. PubMed ID: 38225345
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Tet2-mediated clonal hematopoiesis in nonconditioned mice accelerates age-associated cardiac dysfunction.
    Wang Y; Sano S; Yura Y; Ke Z; Sano M; Oshima K; Ogawa H; Horitani K; Min KD; Miura-Yura E; Kour A; Evans MA; Zuriaga MA; Hirschi KK; Fuster JJ; Pietras EM; Walsh K
    JCI Insight; 2020 Mar; 5(6):. PubMed ID: 32154790
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.
    Frick M; Chan W; Arends CM; Hablesreiter R; Halik A; Heuser M; Michonneau D; Blau O; Hoyer K; Christen F; Galan-Sousa J; Noerenberg D; Wais V; Stadler M; Yoshida K; Schetelig J; Schuler E; Thol F; Clappier E; Christopeit M; Ayuk F; Bornhäuser M; Blau IW; Ogawa S; Zemojtel T; Gerbitz A; Wagner EM; Spriewald BM; Schrezenmeier H; Kuchenbauer F; Kobbe G; Wiesneth M; Koldehoff M; Socié G; Kroeger N; Bullinger L; Thiede C; Damm F
    J Clin Oncol; 2019 Feb; 37(5):375-385. PubMed ID: 30403573
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease.
    Jaiswal S; Libby P
    Nat Rev Cardiol; 2020 Mar; 17(3):137-144. PubMed ID: 31406340
    [TBL] [Abstract][Full Text] [Related]  

  • 97. An inflammatory environment containing TNFα favors Tet2-mutant clonal hematopoiesis.
    Abegunde SO; Buckstein R; Wells RA; Rauh MJ
    Exp Hematol; 2018 Mar; 59():60-65. PubMed ID: 29195897
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Age-related clonal hematopoiesis associated with adverse outcomes.
    Jaiswal S; Fontanillas P; Flannick J; Manning A; Grauman PV; Mar BG; Lindsley RC; Mermel CH; Burtt N; Chavez A; Higgins JM; Moltchanov V; Kuo FC; Kluk MJ; Henderson B; Kinnunen L; Koistinen HA; Ladenvall C; Getz G; Correa A; Banahan BF; Gabriel S; Kathiresan S; Stringham HM; McCarthy MI; Boehnke M; Tuomilehto J; Haiman C; Groop L; Atzmon G; Wilson JG; Neuberg D; Altshuler D; Ebert BL
    N Engl J Med; 2014 Dec; 371(26):2488-98. PubMed ID: 25426837
    [TBL] [Abstract][Full Text] [Related]  

  • 99. ASXL1 mutation in clonal hematopoiesis.
    Fujino T; Kitamura T
    Exp Hematol; 2020 Mar; 83():74-84. PubMed ID: 31945396
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Clonal hematopoiesis in frequent whole blood donors.
    Karpova D
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):299-304. PubMed ID: 38066913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.